Posted by Chantel Martiromo. research contributed by PubMed
Studies conducted in Asian populations have suggested that high consumption of soy-based foods
that are rich in isoflavone phytoestrogens is associated with a reduced
risk of breast cancer. In a prospectively examined associations between
the risk of postmenopausal
invasive breast cancer and dietary intakes of four plant lignans
(pinoresinol, lariciresinol, secoisolariciresinol, and matairesinol) and
estimated exposure to two enterolignans (enterodiol and enterolactone),
as measured with a self-administered diet history questionnaire, among
58,049 postmenopausal French women who were not taking soy isoflavone supplements,posted in PubMed, indicated that During 383,425 person-years of follow-up (median follow-up, 7.7 years),
1469 cases of breast cancer were diagnosed. Compared with women in the
lowest intake quartiles, those in the highest quartile of total lignan
intake (>1395 microg/day) had a reduced risk of breast cancer (RR =
0.83, 95% CI = 0.71 to 0.95, P(trend) = .02, 376 versus 411 cases per
100,000 person-years), as did those in the highest quartile of
lariciresinol intake (RR = 0.82, 95% CI = 0.71 to 0.95, P(trend) = .01).
The inverse associations between phytoestrogen intakes and
postmenopausal breast cancer risk were limited to ER- and PR-positive
disease (e.g., RR for highest versus lowest quartiles of total plant
lignan intake = 0.72, 95% CI = 0.58 to 0.88, P(trend) = .01, 174 versus
214 cases per 100,000 person-years, and RR for highest versus lowest
quartiles of total enterolignan level = 0.77, 95% CI = 0.62 to 0.95,
P(trend) = .01, 164 versus 204 cases per 100,000 person-years).
Chinese Secrets to Fatty Liver and Obesity Reversal
For more information and health articles, please visit women's health http://thetruestoriesstories.blogspot.ca/
No comments:
Post a Comment